First Allylpalladium Systems Containing Chiral Imidazolylpyridine Ligands
FULL PAPER
(S,S)-2,[16] (R,R)-5[14] and (R,R)-6[14] were prepared as described
536.975 for C30H28N3Pd+). H NMR (400 MHz, 298 K): Isomer a
1
previously. NMR spectra were recorded with Varian XL-500 (1H,
(46%): δ = 2.19 (ddd, 1 H, J = 12.4, 1.6, 1.2 Hz), 3.31 (s, 3 H),
standard SiMe4), Varian Gemini (1H, 200 MHz; 13C, 50 MHz; 3.33 (dd, 1 H, J = 7.0, 1.6 Hz), 4.52 (d, 1 H, J = 11.6 Hz), 4.84 (d,
standard SiMe4), Bruker DRX 250 (13C, 62.9 MHz, standard 1 H, J = 10.8 Hz), 4.90 (d, 1 H, J = 10.8 Hz), 5.76 (td, 1 H, J =
SiMe4) and Varian Mercury 400 (1H, 400 MHz; 13C, 100 MHz,
standard SiMe4) spectrometers, using CDCl3 as solvent, unless
stated otherwise. Chemical shifts were reported downfield from
standards. IR spectra were recorded with FTIR Nicolet 520 and
Nicolet 5700 spectrometers. Electron-spray mass spectra were ob-
tained with a Mass ZQ Micromass instrument. High-resolution
mass spectra were obtained with a Waters LCT Premier spectrome-
ter operated in ESI mode. The GC analyses were performed with
a Hewlett-Packard 6890-Network GC system gas chromatograph
[30 m HP5 (5% phenyl)methylpolysiloxane column] with an FID
detector. Enantiomeric excesses were determined by HPLC on a
Chiralcel OD column. Elemental analyses were carried out by the
Serveis Cientifico-Tècnics de la Universitat de Barcelona with an
Eager 1108 microanalyser. Optical rotations were measured with a
JASCO P-1030 polarimeter.
12.1, 7.0 Hz), 6.80–8.35 (aromatic protons, 19 H); Isomer b (31%):
δ = 2.72 (d, 1 H, J = 12.0 Hz), 2.79 (dd, 1 H, J = 7.2, 1.2 Hz), 3.29
(s, 3 H), 4.53 (d, 1 H, J = 11.6 Hz), 4.86 (d, 1 H, J = 10.8 Hz),
5.00 (d, 1 H, J = 11.2 Hz), 5.69 (td, 1 H, J = 12.0, 6.8 Hz), 6.80–
8.35 (aromatic protons, 19 H); Isomer c (15%): δ = 3.21 (s, 3 H),
3.51 (d, 1 H, J = 12.8 Hz), 3.86 (d, 1 H, J = 8.4 Hz), 3.96 (d, 1 H,
J = 11.2 Hz), 4.25 (d, 1 H, J = 7.2 Hz), 4.41 (d, 1 H, J = 8.0 Hz),
5.90 (m, 1 H), 6.80–8.35 (aromatic protons, 19 H) ppm. 13C{1H}
NMR (100.6 MHz): Isomer a (46%): δ = 35.0 (CH3), 55.5 (CH2),
76.9 (CH), 80.2 (CH), 80.3 (CH), 109.4 (CH), 126.0 (CH), 127.0
(CH), 127.8 (CH), 127.9 (CH), 128.3 (CH), 128.8 (CH), 129.1
(CH), 129.2 (CH), 129.5 (CH), 130.0 (CH), 136.4 (C), 137.9 (C),
140.9 (C), 140.9 (CH), 146.6 (C), 149.4 (CH), 165.8 (C=N); Isomer
b (31%): δ = 34.8 (CH3), 55.0 (CH2), 77.0 (CH), 80.2 (CH), 80.9
(CH), 110.2 (CH), 126.1 (CH), 127.2 (CH), 127.7 (CH), 128.0
(CH), 128.4 (CH), 128.8 (CH), 129.0 (CH), 129.1 (CH), 129.5
(CH), 130.0 (CH), 136.2 (C), 137.7 (C), 140.7 (C), 140.9 (CH),
146.5 (C), 149.6 (CH), 165.9 (C=N) ppm.
(4ЈR,5ЈS)-2-(3Ј-Methyl-4Ј,5Ј-diphenyl-2Ј-imidazolyl)pyridine [rac-
(R,S)-3]:
(4ЈR,5ЈS)-2-(4Ј,5Ј-Diphenyl-2Ј-imidazolyl)pyridine[12]
(0.100 g, 0.33 mmol) was dissolved in THF (3 mL) and treated with
NaH (9.5 mg, 0.4 mmol) for 1 h. MeI (22.4 µL, 0.36 mmol) was
then added dropwise at room temperature. After 7 h, the solvent
was removed under reduced pressure, giving a paste, which was
(η3-1,3-Diphenylallyl)[(4ЈS,5ЈS)-2-(3Ј-methyl-4Ј,5Ј-diphenyl-2Ј-imid-
azolyl)pyridine-N,N]palladium(II) Hexafluorophosphate (10): Li-
gand (S,S)-2 (0.075 g, 0.240 mmol) and [Pd(µ-Cl)(η3-1,3-Ph-
C3H3)]2 (0.084 g, 0.13 mmol) were dissolved in dichloromethane
(20 mL) at room temperature under nitrogen overnight. NH4PF6
(0.123 g, 0.760 mmol) was then added and the mixture was stirred
for 24 h. Then the mixture was washed with water (6ϫ15 mL). The
aqueous phase was extracted with dichloromethane (3ϫ10 mL).
All the organic extracts were dried with Na2SO4, filtered and the
solvent was then evaporated to afford a yellow oil. The product
was recrystallised from a mixture of dichloromethane and hexane
purified by column chromatography yielding
a white solid
(77.8 mg, 75%). 1H NMR (200 MHz, CDCl3, 298 K): δ = 8.72–
7.26 (m, 14 H, aromatic), 4.99 (d, 1 H, J = 10.4 Hz), 4.36 (d, 1 H,
J = 10.4 Hz), 2.99 (s, 3 H) ppm. 13C NMR (100.6 MHz, CDCl3,
298 K): δ = 164.6 (C=N), 149.2 (CH), 137.1 (CH), 129.2–127.11
(CH), 125.3 (CH), 124.9 (CH), 79.0 (CH), 77.4 (CH), 34.4 (CH3)
ppm. HRMS-ESI: m/z calcd. for C21H20N3 314.1657; found
314.1647 [M + H]+.
(0.095 g, 52% yield). IR (KBr): ν = 1556 (C=N), 838 (PF ) cm–1.
˜
6
(4ЈS,5ЈS)-2-(3Ј-Benzyl-4Ј,5Ј-diphenyl-2Ј-imidazolyl)pyridine [(S,S)-
4]: (4ЈS,5ЈS)-2-(4Ј,5Ј-Diphenyl-2Ј-imidazolyl)pyridine[16] (0.100 g,
0.33 mmol) was dissolved in THF (3 mL) and treated with NaH
(9.5 mg, 0.4 mmol) for 1 h. Benzyl bromide (42.5 µL, 0.36 mmol)
was then added dropwise at room temperature. After 5 h, the sol-
vent was removed under reduced pressure, giving a brown paste,
which was purified by column chromatography yielding a white
solid (96.6 mg, 75%). 1H NMR (400 MHz, CDCl3, 298 K): δ =
8.73–6.97 (m, 19 H, aromatic), 5.67 (d, 1 H, J = 15.6 Hz), 5.03 (d,
1 H, J = 9.2 Hz), 4.45 (d, 1 H, J = 9.2 Hz), 3.96 (d, 1 H, J =
15.6 Hz) ppm. 13C NMR (100.6 MHz, CDCl3, 298 K): δ = 162.8
(C=N), 148.5 (CH), 136.9 (CH), 128.8–126.9 (CH), 125.6 (CH),
122.6 (CH), 77.4 (CH), 73.6 (CH), 49.1 (CH2) ppm. HRMS-ESI:
m/z calcd. for C27H24N3 390.1970; found 390.1980 [M + H]+.
[α]2D0 –4.90 (c = 0.88, CHCl3).
C36H32F6N3PPd·0.2C4H10O·0.5CH2Cl2 (815.29): calcd. C 54.95, H
4.33, N 5.15; found C 55.09, H 4.02, N 5.07. FAB+ MS: m/z = 613.8
[M – PF6]+ (calcd. 613.077 for C36H32N3Pd+). 1H NMR (400 MHz,
298 K): Isomer a (88%): δ = 3.18 (s, 3 H), 3.83 (d, J = 8.4 Hz, 1
H), 4.11 (d, J = 11.2 Hz, 1 H), 4.41 (d, J = 8.4 Hz, 1 H), 4.81 (d,
J = 11.6 Hz, 1 H), 6.23 (t, J = 11.6 Hz, 1 H), 6.86–8.29 (aromatic
protons, 24 H) ppm. 13C{1H} NMR (100.6 MHz): Isomer a (88%):
δ = 34.6 (CH3), 72.4 (CH), 74.6 (CH), 79.2 (CH), 79.4 (CH), 107.6
(CH), 126.0 (CH), 126.0 (CH), 126.8 (CH), 127.7 (CH), 128.0
(CH), 128.1 (CH), 128.2 (CH), 128.4 (CH), 128.9 (CH), 129.1
(CH), 129.3 (CH), 129.4 (CH), 130.2 (CH), 136.4 (C), 137.4 (C),
138.4 (C), 141.0 (C), 141.1 (CH), 145.9 (C), 149.6 (CH), 165.2
(C=N) ppm.
(η3-1,3-Diphenylallyl)[(4ЈS,5ЈS)-2-(3Ј-benzyl-4Ј,5Ј-diphenyl-2Ј-imid-
azolyl)pyridine-N,N]palladium(II) Hexafluorophosphate (11): Li-
gand (S,S)-4 (0.029 g, 0.075 mmol) and [Pd(µ-Cl)(η3-1,3-Ph-
C3H3)]2 (0.025 g, 0.037 mmol) were dissolved in dichloromethane
(η3-1-Phenylallyl)[(4ЈR,5ЈR)-2-(3Ј-methyl-4Ј,5Ј-diphenyl-2Ј-imid-
azolyl)pyridine-N,N]palladium(II) Hexafluorophosphate (9): Ligand
(R,R)-1 (0.050 g, 0.160 mmol) and [Pd(µ-Cl)(η3-1-Ph-C3H4)]2 (10 mL) at room temperature under nitrogen overnight. NH4PF6
(0.043 g, 0.083 mmol) were dissolved in dichloromethane (25 mL)
at room temperature under nitrogen overnight. NH4PF6 (0.156 g,
0.960 mmol) was then added and the mixture was stirred for 3 h.
Then the mixture was washed with water (6ϫ20 mL). The aqueous
phase was extracted with dichloromethane (3ϫ10 mL). All the or-
ganic extracts were dried with Na2SO4, filtered off and the solvent
was then evaporated to afford a yellow solid. The product was
recrystallised from a mixture of dichloromethane and hexane
(0.037 g, 0.220 mmol) was then added and the mixture was stirred
for 72 h. Then the mixture was washed with water (6ϫ15 mL). The
aqueous phase was extracted with dichloromethane (2ϫ10 mL).
All the organic extracts were dried with Na2SO4, filtered and the
solvent was then evaporated to afford a yellow gum. The product
was recrystallised from a mixture of dichloromethane and hexane
(0.021 g, 33% yield). IR (KBr): ν = 1549 (C=N), 832 (P–F) cm–1.
˜
C42H36F6N3PPd (833.01): calcd. C 60.48, H 4.35, N 5.04; found
(0.061 g, 56% yield). IR (KBr): ν = 1559 (C=N), 838 (PF ) cm–1. 6 0 . 9 0 , H 4 . 9 5 , N 5 . 1 6 . E S I M S : m / z = 6 8 8 . 1 [ M –
˜
6
C30H28F6N3PPd (681.94): calcd. C 52.84, H 4.14, N 6.16; found C
PF6]+ (calcd. 688.194 for C42H36N3Pd+). 1H NMR (500 MHz,
53.28, H 4.26, N 6.02. ESI+ MS: m/z = 536.1 [M – PF6]+ (calcd.
298 K): Isomer a (86%): δ = 3.90 (d, J = 6.0 Hz, H), 4.15 (d, J =
Eur. J. Inorg. Chem. 2007, 132–139
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
137